Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RYR2 | Q92736 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL284982 | 0.60 | RYR2 (0.32) | RYR2KDM4EALDH1A1HPGD | |
| SCHEMBL130274 | 0.60 | RYR2 (0.41) | RYR2KDM4EALDH1A1HPGD | |
| SCHEMBL29750990 | 0.60 | RYR2 (0.32) | RYR2KDM4EALDH1A1HPGD | |
| SCHEMBL3077212 | 0.60 | ALDH1A1 (0.44) | RYR2KDM4EALDH1A1HPGDMAOA | |
| SCHEMBL44494 | 0.60 | RYR2 (0.32) | RYR2KDM4EALDH1A1HPGD | |
| SCHEMBL2873 | 0.59 | RYR2 (0.31) | RYR2KDM4EALDH1A1HPGD | |
| SCHEMBL317331 | 0.59 | RYR2 (0.31) | RYR2KDM4EALDH1A1HPGDMAOA | |
| SCHEMBL3070250 | 0.59 | RYR2 (0.31) | RYR2KDM4EALDH1A1HPGD | |
| SCHEMBL4785009 | 0.59 | MAOA (0.39) | MAOAMAOB | |
| SCHEMBL625812 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11826466-B2 | Bendamustine solution formulations | NAVINTA, LLC (US) | 2023-11-28 | — | — | US | disclosed |
| US-20210169798-A1 | Bendamustine Solution Formulations | PROVIDENT BANK | 2021-06-10 | — | — | US | disclosed |
| US-9452168-B2 | Pyrrole antifungal agents | F2G LTD (GB) | 2016-09-27 | — | — | US | disclosed |
| US-20150238500-A1 | PYRROLE ANTIFUNGAL AGENTS | F2G LTD (GB) | 2015-08-27 | — | — | US | disclosed |
| US-8993574-B2 | Pyrrole antifungal agents | F2G LTD (GB) | 2015-03-31 | — | — | US | disclosed |
| EP-2283006-B1 | PYRROLE ANTIFUNGAL AGENTS | F2G LTD (GB) | 2015-02-25 | — | — | EP | disclosed |
| EP-2626361-B1 | Pyrrole antifungal agents | F2G LTD (GB) | 2014-10-15 | — | — | EP | disclosed |
| EP-2097413-B1 | 2-[(2-SUBSTITUTED)-IND0LIZIN-3-YL]-2-OXO-ACETAMIDE DERIVATIVES AS ANTIFUNGAL AGENTS | F2G LTD (GB) | 2013-12-25 | — | — | EP | disclosed |
| US-8604029-B2 | 2-[(2-substituted)-indolizin-3-yl]-2-oxo-acetamide derivatives as antifungal agents | F2G LTD BRITISH BODY CORPORATE (GB) | 2013-12-10 | — | — | US | disclosed |
| US-8524705-B2 | 2-oxo-2-(2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl)-acetamide derivatives and related compounds as antifungal agents | F2G LIMITED BRITISH BODY CORPORATE (GB) | 2013-09-03 | — | — | US | disclosed |
| EP-0851863-A1 | PHENYLACETIC ACIDS, PROCESSES FOR THEIR PREPARATION AND AGENTS CONTAINING THEM | BASF AKTIENGESELLSCHAFT (DE) | 1998-07-08 | — | — | EP | disclosed |
| WO-1997038996-A1 | HERBICIDAL HETEROCYCLICALLY SUBSTITUTED BENZOYLISOTHIAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-23 | — | — | WO | disclosed |
| EP-0793645-A1 | IMINOOXYMETHYLENE ANILIDES, PROCESS AND INTERMEDIATE PRODUCTS FOR PREPARING THE SAME AND PESTICIDES CONTAINING THE SAME | BASF AKTIENGESELLSCHAFT (DE) | 1997-09-10 | — | — | EP | disclosed |
| WO-1997018187-A1 | AZINOOXIMETHERS, PROCESSES AND INTERMEDIATE PRODUCTS FOR MANUFACTURING SAME, AND THE USES THEREOF IN COMBATING HARMFUL FUNGI AND PESTS | BASF AKTIENGESELLSCHAFT (DE) | 1997-05-22 | — | — | WO | disclosed |
| WO-1997017328-A1 | PYRIDYLACETIC ACID DERIVATIVES, METHOD AND INTERMEDIATE PRODUCTS FOR PRODUCING THEM AND AGENTS CONTAINING THEM | BASF AKTIENGESELLSCHAFT (DE) | 1997-05-15 | — | — | WO | disclosed |
| WO-1997016415-A1 | PHENYLCARBAMATES, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES AND FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-05-09 | — | — | WO | disclosed |
| WO-1997013746-A1 | PHENYLACETIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES AND FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-04-17 | — | — | WO | disclosed |
| WO-1997013747-A1 | OXYAMINO OXIME ETHERS, METHODS AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, AND AGENTS CONTAINING THEM AND USED FOR CONTROLLING HARMFUL FUNGI AND PESTS | BASF AKTIENGESELLSCHAFT (DE) | 1997-04-17 | — | — | WO | disclosed |
| WO-1997011065-A1 | PHENYLACETIC ACIDS, PROCESSES FOR THEIR PREPARATION AND AGENTS CONTAINING THEM | BASF AKTIENGESELLSCHAFT (DE) | 1997-03-27 | — | — | WO | disclosed |
| WO-1996016030-A1 | IMINOOXYMETHYLENE ANILIDES, PROCESS AND INTERMEDIATE PRODUCTS FOR PREPARING THE SAME AND PESTICIDES CONTAINING THE SAME | BASF AKTIENGESELLSCHAFT (DE) | 1996-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11826466-B2 | Bendamustine solution formulations | BHMT, BHMT2, BAD | RYR2 4360/4885KDM4E 1508/4885ALDH1A1 267/4885 |
| US-20210169798-A1 | Bendamustine Solution Formulations | BHMT, BHMT2, BAD | RYR2 4360/4885KDM4E 1508/4885ALDH1A1 267/4885 |
| US-20150238500-A1 | PYRROLE ANTIFUNGAL AGENTS | FOXM1, PYCR1, ARG1 | RYR2 2306/4885KDM4E 1706/4885ALDH1A1 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.